Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medistep HealthcareNSE:MEDISTEP 19 PB Ratio is 0.78 as of Aug. 01, 2026, which is 59% below its 10-year median of 1.92. GuruFocus rates NSE:MEDISTEP with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 112 Medical Distribution companies, Medistep Healthcare ranks better than 72.32% on this metric.
Medistep Healthcare Ltd stock PB Ratio (=0.81) is close to 1-year low of 0.81.
The historical rank and industry rank for Medistep Healthcare's PB Ratio or its related term are showing as below:
NSE:MEDISTEP'
s PB Ratio Range Over the Past 10 Years
Min: 0.74 Med: 1.92 Max: 3.47
Current: 0.79
During the past 4 years, Medistep Healthcare's highest PB Ratio was 3.47. The lowest was 0.74. And the median was 1.92.
NSE:MEDISTEP's PB Ratio is ranked better than 72.32% of 112
companies
in the Medical Distribution industry
Industry Median: 1
vs NSE:MEDISTEP: 0.79
During the past 3 years, the average Book Value Per Share Growth Rate was 270.50% per year.
During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of Medistep Healthcare was 270.50% per year. The lowest was 270.50% per year. And the median was 270.50% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Medistep Healthcare PB Ratio Related Terms
Medistep Healthcare PB Ratio Historical Data
* Premium members only.
The historical data trend for Medistep Healthcare's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:MEDISTEP vs MCK, COR, CAH: PB Ratio Comparison
For the Medical Distribution subindustry, Medistep Healthcare's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medistep Healthcare PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medistep Healthcare's PB Ratio distribution charts can be found below:
* The bar in red indicates where Medistep Healthcare's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Medistep Healthcare (NSE:MEDISTEP) has a PB Ratio of 0.78 as of Aug. 01, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medistep Healthcare and its competitors. This is 59% below median its historical median of 1.92. Over the past decade, Medistep Healthcare's PB Ratio has ranged from 0.74 to 3.47. According to the industry distribution chart, Medistep Healthcare ranks #31 out of 112 companies in the Medical Distribution industry, placing it in the top 27.7%.
Is Medistep Healthcare's PB Ratio too high?
Medistep Healthcare's current PB Ratio of 0.78 is 59% below median its 10-year median of 1.92. Over the past 10 years, this metric has ranged from a low of 0.74 to a high of 3.47. The Medical Distribution industry median PB Ratio is 1.00. Medistep Healthcare's value of 0.78 is 22% below this industry median. Based on the distribution chart, Medistep Healthcare ranks #31 out of 112 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Medistep Healthcare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medistep Healthcare's PB Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Medistep Healthcare ranks #31 out of 112 companies for PB Ratio. This puts Medistep Healthcare in the upper half of its industry. The industry median PB Ratio is 1.00. Medistep Healthcare's value of 0.78 is 22% below this benchmark. Historically, Medistep Healthcare's own PB Ratio has ranged from 0.74 to 3.47 over the past decade. While the company's 10-year median is 1.92 vs. the industry median of 1.00, Medistep Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.00, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medistep Healthcare's current PB Ratio of 0.78 is 22% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medistep Healthcare and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medistep Healthcare's current PB Ratio is 0.78, which is 59% below median its own 10-year median of 1.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistep Healthcare stock overvalued right now?
Medistep Healthcare (NSE:MEDISTEP) has a current PB Ratio of 0.78. The current PB Ratio is 0.78, which is 59% below median its 10-year median of 1.92 and 22% below the Medical Distribution industry median of 1.00. Medistep Healthcare's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Medistep Healthcare (NSE:MEDISTEP), the current PB Ratio is 0.78 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medistep Healthcare Ltd operates in the pharmaceutical and healthcare product sectors. Its business includes manufacturing intimate care and hygiene products such as sanitary pads, as well as nutraceutical products like energy powders. The company also trades a variety of pharmaceutical, surgical, and medical equipment products. Medistep Healthcare's operations focus mainly on the western region of India, particularly in Gujarat. Its Core business activity is divided into the following categories: a) Trading of Pharmaceutical & Surgical products, b) Trading & Manufacturing of Nutraceuticals and Intimate care & hygiene products. The company generates the majority of its revenue from Trading and distribution.
19GF Score
Get the complete analysis for NSE:MEDISTEP
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDISTEP has been successfully added to your 
